Drug intelligence / Profile preview

salvianolic acid C

Development stage
Preclinical
Lead developer
Shanghai Jiao Tong University
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Salvianolic acid C (SAC) is a natural polyphenolic compound extracted from the root of *Salvia miltiorrhiza* (Danshen), a traditional Chinese medicinal herb. It exhibits a broad spectrum of pharmacological activities, including anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic properties. Preclinical studies have demonstrated its therapeutic potential in various conditions, such as acute kidney injury (AKI), hepatic ischemia-reperfusion injury (HIRI), ischemic stroke, and influenza. Mechanistically, salvianolic acid C acts as a selective inhibitor of the m6A reader YTHDF1, a noncompetitive inhibitor of cytochrome P450 2C8 (CYP2C8), and an inhibitor of influenza virus neuraminidase (NA). It also modulates several signaling pathways, including activating the HSP90α/PI3K/Akt cascade, promoting renal gluconeogenesis via PCK1 and FBP1, and inhibiting neuroinflammation through the TLR4-TREM1-NF-κB pathway.

Other names
SACSalCSalvianolic acid C
02

Targets

Sucrase-IsomaltaseACE2 (Angiotensin-converting enzyme 2)BACE1 (Beta-site APP-cleaving enzyme 1)NeuraminidaseSARS-CoV-2 spikeYTHDF1

Beyond the preview

Go deeper on salvianolic acid C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salvianolic acid C.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call